IRhythm Technologies Inc. priced its public offering of common shares, which is set to raise about $100 million.
The San Francisco-based digital healthcare company is selling 1,369,863 shares at $73 apiece.
The company granted a 30-day option to underwriters to purchase up to 205,479 additional shares at the same price.
The offer is expected to close Sept. 10, subject to customary closing conditions.
J.P. Morgan and Morgan Stanley are acting as joint lead book-running managers for the offering, while Canaccord Genuity and BTIG are acting as co-managers.
